Takeda Pharmaceutical Company Limited | Finanzwire

Basculer en Français

10427	Companies
218309	Keywords
147782	Articles
115474	Press releases

Headlines Articles Press releases Takeda Pharmaceutical Company Limited

Home
Companies
Takeda Pharmaceutical Company Limited

BRIEF

published on 05/19/2026 at 11:40, 1 hour 54 minutes ago

Takeda Faces Verdict in AMITIZA® Antitrust Case

Financial Impact Litigation Takeda Antitrust AMITIZA®
PRESS RELEASE

published on 05/19/2026 at 11:35, 1 hour 59 minutes ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Provides an Update regarding Jury Verdict in AMITIZA® (lubiprostone) Antitrust Litigation in the U.S. and Related Revision to FY2025 Financial Results
Takeda reports adverse jury verdict in AMITIZA antitrust case in the U.S., impacting FY2025 financial results. Company to pursue post-trial motions and appeal

Financial Results Takeda Antitrust AMITIZA Jury Verdict
BRIEF

published on 03/25/2026 at 09:35, 1 month 25 days ago

Takeda Outlines Strategic Transformation for Future Growth

Growth Strategy Financial Forecast Corporate Restructuring Pharmaceutical Innovation Takeda Transformation
PRESS RELEASE

published on 03/25/2026 at 09:30, 1 month 25 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook
Takeda announces next steps in its transformation to strengthen competitiveness and accelerate future growth outlook, positioning the company for its next era

Transformation Growth Takeda Competitiveness Efficiencies
BRIEF

published on 10/30/2025 at 07:48, 6 months 20 days ago

Takeda Revises Financial Forecast for FY2025

Revenue Decline Financial Forecast Takeda FY2025 Profit Reduction
PRESS RELEASE

published on 10/30/2025 at 07:43, 6 months 20 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
Takeda Pharmaceutical Company Limited revises FY2025 financial forecast due to strategic pipeline decisions and FX impact

Financial Forecast Revised Forecast Impairment Charges Takeda Pharmaceutical FY2025
BRIEF

published on 01/30/2025 at 09:36, 1 year 3 months ago

Julie Kim to Take Over as CEO of Takeda in 2026

Takeda CEO Transition Julie Kim Christophe Weber Retirement Pharmaceutical Leadership Corporate Succession
PRESS RELEASE

published on 01/30/2025 at 09:31, 1 year 3 months ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Julie Kim to succeed Christophe Weber as CEO of Takeda in June 2026. Board unanimously appoints her to lead after Weber's 12 successful years. Succession process concluded

Takeda Leadership CEO Succession Julie Kim Christophe Weber
BRIEF

published on 01/30/2025 at 07:35, 1 year 3 months ago

Takeda Pharmaceutical Revises FY2024 Financial Forecast

Revenue Growth Financial Performance Operating Profit FY2024 Forecast Takeda Pharmaceutical
PRESS RELEASE

published on 01/30/2025 at 07:30, 1 year 3 months ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Pharmaceutical Company Limited announces revised financial forecast for FY2024, showing positive growth across revenue, profit, and earnings per share

Financial Forecast Takeda FY2024 Revised Forecast Core Financial Measures

Accesswire

Published on 05/19/2026 at 13:00, 34 minutes ago

Formation Metals Announces Upsize Of Non-Brokered Offering Of Up To $22 Million To Increase Drill Program To 75,000 Metres
Published on 05/19/2026 at 13:00, 34 minutes ago

Troubadour Resources Announces Strategic Exploration Shift to Amarillo Copper Porphyry Project
Published on 05/19/2026 at 13:00, 34 minutes ago

Silver Tiger Metals Announces Graduation to the Toronto Stock Exchange
Published on 05/19/2026 at 13:00, 34 minutes ago

Meta Critical Minerals Commences Environmental Baseline Studies at Table Mountain Silica Project, BC
Published on 05/19/2026 at 12:30, 1 hour 4 minutes ago

White Gold Corp. Identifies High-Priority Copper, Gold & Multi Element Porphyry and Epithermal Targets at Guilder and Mt. Hart Targets Following IP Geophysics Program

View all ACCESSWIRE

EQS Group

Published on 05/19/2026 at 13:20, 13 minutes ago

North Peak Resources Secures All Required Permits for 2026 Drilling
Published on 05/19/2026 at 13:15, 19 minutes ago

LR HEALTH & BEAUTY SE INITIATES A WRITTEN PROCEDURE UNDER ITS OUTSTANDING BOND LOAN IN RESPECT OF A COMPREHENSIVE RESTRUCTURING, PUBLISHES A PROSPECTUS FOR SUBSCRIPTION OF BONDS AND INVITES...
Published on 05/19/2026 at 13:05, 28 minutes ago

Fractus targets fast-rising connected logistics market with new asset tracking deal
Published on 05/19/2026 at 13:05, 28 minutes ago

Rockwell Automation Report Highlights German Manufacturers Combining Record Digital Investment with Rising Cyber Exposure and Execution Pressure
Published on 05/19/2026 at 13:05, 28 minutes ago

90% of Manufacturers Say Digital Transformation Is Now Essential, According to New Global Study

Les Echos

Published on 05/18/2026 at 22:25, 15 hours 8 minutes ago

Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares
Published on 05/18/2026 at 18:00, 19 hours 34 minutes ago

Covivio Hotels - Covivio continues its expansion in hospitality in Southern Europe with a new acquisition in Torremolinos, Spain
Published on 05/18/2026 at 17:45, 19 hours 49 minutes ago

Weekly share buyback
Published on 05/18/2026 at 17:43, 19 hours 51 minutes ago

Aéroports de Paris S.A - April 2026 traffic figures
Published on 05/18/2026 at 17:41, 19 hours 52 minutes ago

Reporting on share buyback transactions carried out between May 13 and May 15, 2026

View all LES ECHOS COMFI WIRE